CompletedNCT06138691
KET-RO and RO DBT for treatment-resistant depression
About this title
Read the official source — NCT06138691Interventional studyAges 18–65United States
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- St LouisSee all locations and recruitment
Study information
Study start dateStarted: October 4, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Combination product
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06138691
- Official title
Show the full official title
Medication-assisted Psychotherapy: Using Ketamine-enhanced Radically Open Dialectical Behavior Therapy (RO DBT) to Target Neural and Behavioral Mechanisms of Action in Adults With Moderate to Severe Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
St Louis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Washington University School of Medicine, a university.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
